Clinical Trial Assessment of the effect of Diclofenac gel and EMLA ointment
Phase 3
- Conditions
- Condition 1: Diclofenac gel on vein puncture pain severity with vein catheter. Condition 2: EMLA ointment on vein puncture pain severity with vein catheter.Other nonsteroidal anti-inflammatory drugsLocal anaesthetics
- Registration Number
- IRCT201008234618N1
- Lead Sponsor
- Sediqeh Khalili (personal)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 90
Inclusion Criteria
Study Entry Requirements: aged 18 to 40 years; don’t have any defect in terms of mental and visual and verbal ability; Patients who doesn’t have any sensitivity to local anaesthetics or allergy to NSAIDs; haven’t used analgesics during the previous 24 hours; don’t have Favism, methemoglobin, liver and kidney disease, asthma, skin allergies, skin dermatitis, wound in the area assigned for intervention, active gastrointestinal bleeding, allergies to topical anaesthetics and non steroidal anti-inflammatory drugs included in this study. Study Exclusion: if the insertion vein catheter be unsuccessful in the first attempt or the caesarean section become an emergency operation.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Vein puncture pain severity with vein catheter. Timepoint: 3-5 minutes after vein catheter installation. Method of measurement: Visual analogue scale.
- Secondary Outcome Measures
Name Time Method Short-term effects of topical drugs diclofenac gel, anesthetic cream EMLA and vaseline cream. Timepoint: application local medications later One hour. Method of measurement: Checklist of short-term effects of topical drugs.